fluorodeoxyglucose f18 has been researched along with Lymphoma, B-Cell in 133 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (0.75) | 18.2507 |
2000's | 60 (45.11) | 29.6817 |
2010's | 59 (44.36) | 24.3611 |
2020's | 13 (9.77) | 2.80 |
Authors | Studies |
---|---|
Carvalho, IP; Esteves, S; Freitas, AC; Gomes da Silva, M; Salgado, L | 1 |
Nakatani, K; Notohara, K; Saito, K; Sakata, E; Ueda, Y | 1 |
Easow, J; Govindaraj, J; Lakshmanan, A; Muthu, A; Narla, S; Raja, T; Ramalingam, TR; Simon, S; Subramanyan, A; Vaidhyanathan, L | 1 |
Alessi, A; Argiroffi, G; Bagnoli, F; Carniti, C; Chiappella, A; Corradini, P; Dodero, A; Guidetti, A; Lorenzoni, A; Marasco, V; Monfrini, C; Pennisi, M; Pizzamiglio, S; Seregni, E; Verderio, P | 1 |
Borte, G; Denecke, T; Franke, GN; Georgi, TW; Herling, M; Hoffmann, S; Jentzsch, M; Kluge, R; Kurch, L; Merz, M; Metzeler, K; Perez-Fernandez, C; Petermann, N; Platzbecker, U; Sabri, O; Schwind, S; Vučinić, V | 1 |
Li, S; Lu, X; Wang, G; Wang, H; Yang, J | 1 |
Amitay-Laish, I; Bairey, O; Barzilai, A; Even-Sapir, E; Feinmesser, M; Feuerman, H; Hodak, E; Mimouni, D; Snast, I | 1 |
Lijun, Z; Xiao-Xue, W; Xinyue, H | 1 |
Alsayed, Y; Edesa, W; Hussein, M; Kandeel, AA; Younis, J; Zidan, L | 1 |
Ahmed, G; El Semary, SF; Kenaai, NE; Nagy, N; Omar, W; Rahman, HA; Zaky, I | 1 |
Almeida, FA; Bribriesco, A; Koyfman, S; Krishnan, S; Phillips, W; Rotz, SJ; Thind, GS; Yun, J; Zahniser, M; Zembillas, A | 1 |
Sharma, P | 1 |
Bachy, E; Bouafia, F; Brisou, G; Carras, S; Cavalieri, D; Choquet, M; Dhomps, A; Ferrant, E; Fouillet, L; Ghergus, D; Ghesquières, H; Golfier, C; Guillermin, Y; Hequet, O; Hospital-Gustem, C; Janier, M; Karlin, L; Lazareth, A; Lebras, L; Lequeu, H; Leyronnas, C; Mialou, V; Novelli, S; Safar, V; Salles, G; Schwiertz, V; Sesques, P; Sujobert, P; Tordo, J; Vercasson, M; Wallet, F | 1 |
Desclaux, A; Lazaro, E; Pinaquy, JB; Viallard, JF; Yacoub, M | 1 |
Arfi-Rouche, J; Danu, A; Dartigues, P; Fermé, C; Florea, V; Ghez, D; Ghigna, MR; Lazarovici, J; Michot, JM; Mussot, S; Petrovanu, C; Ribrag, V; Terroir, M | 1 |
Abe, R; Jinzaki, M; Karigane, D; Kato, J; Kikuchi, T; Koda, Y; Mori, T; Nakahara, T; Nakazato, T; Okamoto, S; Sakurai, M; Shimizu, T; Toyama, T; Yamane, Y; Yamazaki, R | 1 |
Hatanaka, Y; Hokkoku, K; Matsukura, K; Sasajima, Y; Shiraoka, A; Sonoo, M; Tada, Y; Takahashi, Y; Yang, L | 1 |
Adams, HJA; Alkhawtani, RHM; Balink, H; Glaudemans, AWJM; Huls, G; Kwee, TC; Nijland, M; Noordzij, W; van der Galiën, HT; van Meerten, T; van Rijn, RS | 1 |
Bal, A; Bhattacharya, A; Kumar, R; Mittal, BR; Prakash, G; Singh, H; Vadi, SK | 1 |
Cottereau, AS; Meignan, M | 1 |
Adams, HJA; Kwee, TC | 1 |
Melani, C; Roschewski, M; Wilson, WH | 1 |
Abid, MB; Chan, EHL; de Mel, S; Loi, HY; Poon, LM; Wang, S | 1 |
Alashkar, F; Behringer, D; Bengel, FM; Bernhard, H; Brink, I; Brinkmann, M; Dienst, A; Dührsen, U; Dürig, J; Franzius, C; Freesmeyer, M; Ganser, A; Gaska, T; Giagounidis, A; Griesshammer, M; Grube, M; Hahn, D; Hautzel, H; Hertel, A; Hertenstein, B; Hoelzer, D; Höffkes, HG; Höhler, T; Holzinger, J; Hüttmann, A; Jöckel, KH; Klapper, W; Klein, A; Kotzerke, J; Krohn, T; Kroschinsky, F; Kurch, L; La Rosée, P; Marienhagen, J; Maschmeyer, G; Mesters, R; Müller, SP; Naumann, R; Nückel, H; Ose, C; Pöpperl, G; Prange-Krex, G; Raghavachar, A; Rekowski, J; Römer, W; Schmitz, C; Schroers, R; Schütte, J; Schwarzer, A; Steiniger, H; Südhoff, T; Weckesser, M; Wilop, S | 1 |
Ceriani, L; Giovanella, L; Johnson, PWM; Martelli, M; Milan, L; Presilla, S; Zucca, E | 1 |
Fujimori, Y; Kashiwagi, T; Kitajima, K; Okada, M; Sawada, A; Tokugawa, T; Yamakado, K; Yoshihara, K; Yoshihara, S | 1 |
Dawson, LP; Kranz, S; Pol, D; Sivaratnam, D | 1 |
Chen, S; Feng, F; Fu, H; He, K; Wang, H; Wang, S; Yin, Y | 1 |
Cheon, M; Choi, JY; Hyun, SH; Kim, H; Kim, J; Lee, KS; Shim, YM; Yoo, J; Zo, JI | 1 |
Chang, PJ; Hsiao, PC; Kao, PF; Kao, YL; Lee, JK; Ting, WC | 1 |
Bellò, M; Bisi, G; Caracciolo, D; Chiappella, A; Douroukas, A; Filippi, AR; Giunta, F; Piva, C; Ragona, R; Ricardi, U; Vitolo, U; Zotta, M | 1 |
Chen, Y; Li, C; Li, F; Shen, Z; Tian, J; Wang, R; Xu, B; Yu, L; Zhu, H | 1 |
Csekeo, A; Csomor, J; Eszes, N; Kis, A; Losonczy, G; Muller, V; Tamasi, L | 1 |
Allen, CE; Bollard, CM; Dreyer, Z; Eissa, HM; Goradia, P; Guillerman, RP; Kamdar, K; McClain, KL; Simko, S; Steuber, P | 1 |
Fujii, H; Matsumoto, M; Morimoto, A; Nakamichi, K; Nakamura, T; Saijo, M; Ueno, H; Yukitake, M | 1 |
Castro-Malaspina, H; Devlin, SM; Fleming, SE; Lechner, L; Moskowitz, CH; Sauter, CS; Scordo, M; Zheng, J | 1 |
Burbury, KL; Carney, DA; Cheah, CY; Dickinson, M; Harrison, SJ; Herbert, KE; Hofman, MS; Januszcewicz, EH; Prince, HM; Ritchie, DS; Seymour, JF; Tam, CS; Wirth, A; Wolf, M | 1 |
Pangalis, GA; Polliack, A; Vassilakopoulos, TP | 1 |
Bahure, S; Cheung, JC; Lin, M | 1 |
Chekol, S; Chong, EA; Glatstein, E; Nagle, SJ; Nasta, SD; Plastaras, JP; Schuster, SJ; Shah, NN; Svoboda, J; Torigian, DA | 1 |
Goedel, A; Götze, K; Hoellein, A; Rischpler, C | 1 |
Bots, M; Cullinane, C; Martin, BP; Newbold, A | 1 |
Dunleavy, K; Wilson, WH | 1 |
Ding, C; Ding, Q; Li, T; Sun, J; Xu, X; Yang, W | 1 |
Chang, CC; Chang, CS; Cho, SF; Hsiao, HH; Huang, CT; Lin, SF; Liu, TC; Liu, YC | 1 |
Cascavilla, A; Legnani, G; Magistrelli, E; Manfredi, R; Sabbatani, S | 1 |
Liu, X; Wang, R; Xu, H; Xu, K | 1 |
Bellò, M; Bisi, G; Caracciolo, D; Chiappella, A; Filippi, AR; Levis, M; Piva, C; Ricardi, U; Vitolo, U | 1 |
Liu, YM; Wu, YW; Zhai, XM | 1 |
Bazargan, A; Colman, P; Hicks, RJ; Hofman, MS; Pattison, DA | 1 |
Balzarotti, M; Cabrera, ME; Ceriani, L; Chiappella, A; Cunningham, D; Ferreri, AJ; Giovanella, L; Gospodarowicz, MK; Guarini, A; Johnson, PW; Martelli, M; Ricardi, U; Stelitano, C; Zinzani, PL; Zucca, E | 1 |
Bund, C; Fohrer, C; Heimburger, C; Kremer, S; Namer, IJ; Trensz, P | 1 |
Fukumoto, T; Imataki, O; Kitanaka, A; Kubota, Y; Kurokohchi, K; Ohnishi, H; Tanaka, T | 1 |
Byun, BH; Cheon, GJ; Choi, CW; Kang, HJ; Kim, KM; Lee, SS; Lim, SM; Na, II; Ryoo, BY; Yang, SH | 1 |
Davies, AJ; Johnson, PW | 1 |
Ambinder, RF; Blackford, AL; Bolaños-Meade, J; Borowitz, MJ; Fidyk, CA; Goodman, SN; Jones, RJ; Kasamon, YL; Rogers, KM; Swinnen, LJ; Wahl, RL; Ziessman, HA | 1 |
Kim, H; Kim, SE; Lee, WW; Park, SY; Shim, HK; So, Y | 1 |
Hee, SW; Lim, LC; Lim, ST; Ng, DCE; Ngeow, JYY; Quek, RHH; Tan, YH; Tao, M | 1 |
Galanski, M; Joerdens, S; Kiesel, H; Knapp, WH; Rodt, T; von Falck, C; Waldeck, S | 1 |
Fan, W; Ma, LF | 1 |
Blockx, P; Ceyssens, S; Geens, K; Parizel, PM; van den Hauwe, L; Van den Wyngaert, T | 1 |
Busch, V; Hillebrand, U; Pavenstädt, H; Rahbar, K; Reuter, S; Schober, O; Stegger, L; Velden, J | 1 |
De Falco, T; De Renzo, A; Erra, P; Klain, M; Nardelli, A; Pace, L; Pellegrino, T; Perna, F; Rotoli, B; Speranza, A; Storto, G | 1 |
Ravi, V; Seltzer, M; Siegel, A; Silas, AM | 1 |
Bouabdallah, R; Coso, D; Rey, J | 1 |
Iwasaki, M; Oshima, K; Sakaura, H; Yamashita, T; Yoshikawa, H | 1 |
Balzarini, J; Brepoels, L; De Saint-Hubert, M; Mortelmans, L; Mottaghy, FM; Stroobants, S; Verhoef, G | 1 |
Derbekyan, V; Hickeson, M; Makis, W | 1 |
Adalet, I; Dogan, O; Erten, N; Kilicaslan, I; Saka, B; Sanli, Y; Turkmen, C | 1 |
Au, WY; Chan, WK; Khong, PL; Kwong, YL; Leung, AY; Liang, R; Wong, CY | 1 |
Bartlett, NL; Cashen, AF; Dehdashti, F; Homb, A; Luo, J; Siegel, BA | 1 |
Ahmad, A; Barakat, FH; Chuang, HH; Fowler, NH; Habra, MA; Myers, JN; Shahani, S; Stava, C | 1 |
Shrikanthan, S; Talanow, R | 1 |
David, SP; MacManus, MP; Rees, HS | 1 |
Adrada, BE; Carkaci, S; Whitman, GJ | 1 |
Ichimura, K; Matsuo, T; Yoshino, T | 1 |
Berlangieri, S; Lee, ST; Thientunyakit, T | 1 |
Dang, CJ; Li, YJ; Zhan, FH | 1 |
Kano, T; Kubota, K; Mimori, A; Suzuki, A; Takahashi, Y; Yamashita, H | 1 |
Kaneko, K; Masunari, S; Omagari, J; Yoshida, T | 1 |
Salm, LP; Stokkel, MP; Van der Hiel, B | 1 |
Bailly, C; Bodet-Milin, C; Dupas, B; Eugène, T; Gastinne, T; Kraeber-Bodéré, F; Le Gouill, S | 1 |
Ceccarelli, S; Lacanfora, A; Schillaci, O; Simonetti, G; Travascio, L | 1 |
Alavi, A; Fried, RG; Junkins-Hopkins, JM; Rook, AH; Saidman, BH; Schulman, N; Shapiro, M; Vittorio, CC; Yun, M | 1 |
Becherer, A; Chott, A; Hoffmann, M; Jäger, U; Kletter, K; Raderer, M | 1 |
Cheong, KA; Kirkwood, ID; Rodgers, NG | 1 |
Hayashi, K; Honda, H; Kaneko, K; Koga, H; Kuwabara, Y; Matsuo, Y; Nakagawa, M; Sasaki, M | 1 |
Bosly, A; Krug, B; Luyx, D; Mathieu, I; Pirson, AS; Sonet, A; Vander Borght, T; Willemart, B | 1 |
Biancari, F; Biffoni, M; Marchesi, M | 1 |
Lee, MH; Yoon, JK; Yoon, SN | 1 |
Forero-Torres, A; Mahone, T; Muthukrishnan, A; Ojha, B; Raman, AK; Satya, R | 1 |
Kawai, N; Masada, T; Matsumoto, Y; Nagao, S; Tamiya, T | 1 |
Chang, CP; Chu, YK; Hsieh, HJ; Lin, SH; Liu, RS | 1 |
Balan, KK; Cheow, HK; Groves, AM; Win, T | 1 |
Cohen, AM; Even-Sapir, E; Kanter, P; Marmelstein, V; Metser, U; Stein, GY; Streifler, J; Zeidman, A | 1 |
Kim, EK; Kim, MJ; Oh, KK; Park, SY; Yun, M | 1 |
Rosenberg, RJ; Solis, V; Spencer, RP | 1 |
Alavi, A; Dhurairaj, T; Kumar, R; Xiu, Y; Yu, JQ; Zhuang, H | 1 |
Bonardel, G; Foehrenbach, H; Gontier, E; Mantzarides, M; Papathanassiou, D; Soret, M | 1 |
Arshanskiy, Y; Carpino, P; Coyner, K; Daoust, P; Erban, J; Foote, C; Kimmelstiel, C; Kuvin, J; Pandian, NG; Parikh, N; Rastegar, H; Salomon, R; Tischler, A | 1 |
Kawai, N; Kawanishi, M; Nagao, S; Tamiya, T | 1 |
Becherer, A; Hauswirth, A; Hoffmann, M; Jaeger, U; Kletter, K; Raderer, M; Turetschek, K; Wöhrer, S | 1 |
Ali, A; Cyriac, J; Karam, M; Nazeer, T; Novak, L; Nugent, F | 1 |
Berthelot, C; Blaire, T; Bouchet, F; Cahouet, A; Foussard, C; Giraud, S; Jeanguillaume, C; Lacoeuille, F; Lejeune, JJ; Metrard, G; Morel, O; Rakotonirina, H; Truchan-Graczyk, M | 1 |
Alavi, A; Kumar, R; Xiu, Y; Zhuang, HM | 1 |
Lu, MT; Menard, MT; Millstine, J; Rybicki, FJ; Viscomi, S | 1 |
Joyce, RM; Parker, JA; Williams, G | 1 |
Aoki, T; Asada, N; Matsue, K; Odawara, J; Ohuchi, T; Takeuchi, M; Yamakura, M | 1 |
Rademaker, J | 1 |
Chaise, C; Copie-Bergman, C; Delfau-Larue, MH; Farcet, JP; Itti, E; Meignan, M; Molinier-Frenkel, V; Petegnief, Y; Talbot, JN; Wirquin, E | 1 |
Besses, C; Calvo, N; Carrera, MJ; Conangla, M; Puget, G; Salar, A; Sitges-Serra, A; Trampal, C | 1 |
Fields, P; Hofman, MS; Ireland, R; Mikhaeel, NG; Nunan, T; Yung, L | 1 |
Karantanis, D; Mullan, BP; O'Neill, BP; Peller, PJ; Subramaniam, RM; Wiseman, GA; Witte, RJ | 1 |
Hicks, RJ; Hogg, A; Januszewicz, H; Lee, M; Macmanus, M; Ng, AP; Prince, HM; Seymour, JF; Wirth, A; Wolf, M | 1 |
Akdemir, UO; Benekli, M; Buyukberber, S; Coskun, U; Kapucu, O; Kaya, AO; Yildiz, R | 1 |
Brière, J; Copie-Bergman, C; Dupuis, J; El Gnaoui, T; Gaillard, I; Gaulard, P; Gisselbrecht, C; Haioun, C; Hemery, F; Itti, E; Meignan, M; Rahmouni, A | 1 |
Arsos, G; Baarslag, HJ; de Klerk, JM; Weijs, LE; Wittebol, S | 1 |
Forman, S; Kirschbaum, MH; Rotter, A; Weiss, L; Zain, J | 1 |
Castaldi, P; Maussier, ML; Melis, L; Perotti, G; Rubello, D; Rufini, V; Salvatori, M | 1 |
Bruzzi, J; Giles, F; Swords, R | 1 |
Al-Nahhas, A; Banti, E; Bianchini, E; D'Andrea, E; Muzzio, PC; Paolini, R; Rubello, D | 1 |
Brepoels, L; De Wever, W; De Wolf-Peeters, C; Mortelmans, L; Spaepen, K; Stroobants, S; Thomas, J; Uyttebroeck, A; Vandenberghe, P; Verhoef, G | 1 |
Demura, Y; Fujibayashi, Y; Imamura, Y; Okazawa, H; Tsuchida, T; Tsujikawa, T | 1 |
Hattori, M; Hoshikawa, Y; Kusumoto, S; Matsukawa, N; Oguri, T; Ojika, K; Uematsu, N; Yamawaki, T | 1 |
Amrein, PC; Hales, CA; Kradin, RL; Meyer, GS; Sharma, A | 1 |
Dupuis, J; Haioun, C; Itti, E; Lin, C; Luciani, A; Meignan, M; Paone, G; Petegnief, Y; Rahmouni, A; Talbot, JN | 1 |
Chu, J; Kilanowska, J; Lin, M; Taper, J | 1 |
Fuertes, S; Fuster, D; Lomeña, F; López-Guillermo, A; Montserrat, E; Paredes, P; Pons, F; Setoain, X | 1 |
Avram, AM; Dong, Q; Wong, KK | 1 |
Belakhlef, A; Church, C; Fraser, R; Jani, C; Lakhanpal, S | 1 |
Ben Jilani Baltaji, S; Ben Slama, MR; Bouasker, I; Bouzouita, A; Chebil, M; Kourda, N; Sfaxi, M | 1 |
Beaney, RP; Chevretton, EB; Walsh, RM; Wong, WL | 1 |
Alavi, A; Ghesani, N; Hongming, Z; Mozley, D; Schusper, S; Shih, WJ | 1 |
5 review(s) available for fluorodeoxyglucose f18 and Lymphoma, B-Cell
Article | Year |
---|---|
Whole body FDG-PET/CT for the assessment of bone marrow infiltration in patients with newly diagnosed lymphoma.
Topics: Adult; Aged; Biopsy; Bone Marrow; Bone Marrow Examination; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ilium; Liver; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Whole Body Imaging; Young Adult | 2020 |
Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?
Topics: Antibodies, Monoclonal, Murine-Derived; B-Lymphocytes; Decision Making; Drug Therapy; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Hodgkin Disease; Humans; Immunophenotyping; Immunotherapy; Lymphoma; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Mediastinum; Positron-Emission Tomography; Recurrence; Rituximab; Treatment Outcome | 2015 |
Primary mediastinal B-cell lymphoma.
Topics: Age Distribution; Aged; Chromosome Aberrations; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Lymphoma, B-Cell; Mediastinal Neoplasms; Middle Aged; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Positron-Emission Tomography; Radioisotopes; Survival Rate; Tomography, X-Ray Computed; Transcription, Genetic | 2008 |
[Primary mediastinal B-cell lymphoma].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Mediastinal Neoplasms; Positron-Emission Tomography; Prognosis; Radiotherapy, Adjuvant; Rituximab; Young Adult | 2010 |
Recent advances in the diagnosis and therapy of Richter's syndrome.
Topics: Antineoplastic Agents; Cell Transformation, Neoplastic; Citrates; Fluorodeoxyglucose F18; Gallium; Gallium Radioisotopes; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Positron-Emission Tomography; Radiopharmaceuticals; Syndrome | 2007 |
3 trial(s) available for fluorodeoxyglucose f18 and Lymphoma, B-Cell
Article | Year |
---|---|
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, B-Cell; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Rituximab; Survival Rate; Vincristine | 2019 |
Pretransplantation fluorine-18-deoxyglucose--positron emission tomography scan lacks prognostic value in chemosensitive B cell non-hodgkin lymphoma patients undergoing nonmyeloablative allogeneic stem cell transplantation.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous | 2014 |
Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanning.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Platinum Compounds; Positron-Emission Tomography; Prognosis; Risk Assessment; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Young Adult | 2009 |
125 other study(ies) available for fluorodeoxyglucose f18 and Lymphoma, B-Cell
Article | Year |
---|---|
End of treatment FDG-PET in primary mediastinal B-cell lymphoma treated with R-chemotherapy: Prognostic indicator and implications for consolidation radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Decision-Making; Combined Modality Therapy; Cyclophosphamide; Disease Management; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Retreatment; Rituximab; Treatment Outcome; Vincristine | 2022 |
Diffuse
Topics: Aged; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Role of high acquisition flow cytometry in the detection of marrow involvement in patients with extramedullary B cell non-Hodgkins lymphoma: a comparison with marrow aspirate cytology, trephine biopsy, and PET.
Topics: Biopsy; Bone Marrow; Flow Cytometry; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Positron-Emission Tomography; Retrospective Studies | 2022 |
Combination of Deauville score and quantitative positron emission tomography parameters as a predictive tool of anti-CD19 chimeric antigen receptor T-cell efficacy.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies; Receptors, Chimeric Antigen; Retrospective Studies; T-Lymphocytes | 2023 |
Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy.
Topics: Cell- and Tissue-Based Therapy; Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Receptors, Chimeric Antigen | 2023 |
Chimeric Antigen Receptor T-Cell Therapy of Neurolymphomatosis Monitored by FDG PET/CT.
Topics: Adult; Cell- and Tissue-Based Therapy; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Neoplasm Recurrence, Local; Neurolymphomatosis; Positron Emission Tomography Computed Tomography; Receptors, Chimeric Antigen | 2023 |
The Utility of 18F-fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Cutaneous B-Cell Lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Skin; Skin Neoplasms; Young Adult | 2019 |
Diagnostic performance of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography in identifying bone marrow infiltration in new patients with diffuse large B-cell lymphoma and Hodgkin lymphoma.
Topics: Adult; Aged; Bone Marrow Neoplasms; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ilium; Lymphoma, B-Cell; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2020 |
Can FDG-PET replace biopsy for the evaluation of residual tumor in pediatric mature B-cell non-Hodgkin lymphoma?
Topics: Adolescent; Biopsy; Child; Child, Preschool; Cross-Sectional Studies; Egypt; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity | 2020 |
Continuous infusion chemotherapy, radiotherapy, and FDG-PET are feasible during extracorporeal membrane oxygenation.
Topics: Adolescent; Chemoradiotherapy; Extracorporeal Membrane Oxygenation; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Positron-Emission Tomography | 2020 |
18F-FDG PET/CT of Double Expressor High-Grade B-Cell Lymphoma in an Isolated Chest Wall Mass.
Topics: Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Neoplasm Grading; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Thoracic Wall | 2021 |
Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells.
Topics: Adult; Aged; Fluorodeoxyglucose F18; Glycolysis; Humans; Immunotherapy, Adoptive; Lymphoma, B-Cell; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Receptors, Chimeric Antigen; Retrospective Studies; T-Lymphocytes; Tumor Burden | 2021 |
Renal Intravascular Large B-cell Lymphoma: A Case Report and Review of the Literature.
Topics: Biopsy; Female; Fluorodeoxyglucose F18; Humans; Kidney; Lymphoma, B-Cell; Middle Aged; Vascular Neoplasms | 2017 |
Poor predictive value of positive interim FDG-PET/CT in primary mediastinal large B-cell lymphoma.
Topics: Adolescent; Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; Young Adult | 2017 |
Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography with gallium-67 scintigraphy in the initial clinical staging of diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2018 |
Increased uptake on
Topics: Aged; Biopsy; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin; Skin Neoplasms | 2018 |
Lactate dehydrogenase levels and 18F-FDG PET/CT metrics differentiate between mediastinal Hodgkin's lymphoma and primary mediastinal B-cell lymphoma.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lactate Dehydrogenases; Lymphoma, B-Cell; Male; Mediastinum; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve | 2018 |
Incidental Detection of an Unusual Case of B-Cell Lymphoma of the Urachal Remnant on 18F-FDG PET/CT.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Urachus; Urologic Neoplasms | 2018 |
FDG-PET in PMBCL: which heterogeneity?
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Mediastinal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2018 |
Unproven value of end-of-treatment and serial follow-up FDG-PET in primary mediastinal B-cell lymphoma.
Topics: Clinical Decision-Making; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, B-Cell; Positron-Emission Tomography | 2018 |
End-of-treatment and serial PET imaging has prognostic value and clinical utility in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R - Response to Adams
Topics: Cyclophosphamide; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, B-Cell; Positron-Emission Tomography; Prognosis; Vincristine | 2018 |
Extreme exigency in the extremity: an illustrative case of diffuse large B-cell lymphoma occurring in the arm.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Flow Cytometry; Fluorodeoxyglucose F18; Forearm; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prednisone; Rituximab; Vincristine | 2018 |
Baseline PET features to predict prognosis in primary mediastinal B cell lymphoma: a comparative analysis of different methods for measuring baseline metabolic tumour volume.
Topics: Algorithms; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Mediastinal Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Risk; Software; Tumor Burden | 2019 |
Early evaluation of tumor response to
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; B-Lymphocytes; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Radioimmunotherapy; Radionuclide Imaging | 2019 |
Pericardial constriction in double-hit lymphoma.
Topics: Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Metabolic tumor burden on baseline
Topics: Adolescent; Child; Child, Preschool; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphoma, B-Cell; Male; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Retrospective Studies; Risk Assessment; Tumor Burden | 2019 |
Diagnostic Performance of ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/CT for Chronic Empyema-Associated Malignancy.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Empyema; Female; Fistula; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2019 |
Dynamic FDG PET/CT imaging with diuresis demonstrates an enterovesical fistula in a lymphoma patient with repeated colon diverticulitis.
Topics: Adult; Diuresis; Diverticulitis, Colonic; Fluorodeoxyglucose F18; Humans; Intestinal Fistula; Lymphoma, B-Cell; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Urinary Bladder Fistula | 2013 |
Radiation therapy in primary mediastinal B-cell lymphoma with positron emission tomography positivity after rituximab chemotherapy.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Rituximab; Young Adult | 2013 |
Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT.
Topics: Adolescent; Adult; Aged; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed; Young Adult | 2014 |
Sarcoidosis lymphoma syndrome - the value of PET-CT in the diagnosis.
Topics: Antineoplastic Agents, Alkylating; Cyclophosphamide; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, B-Cell; Middle Aged; Positron-Emission Tomography; Prognosis; Radiography, Thoracic; Radiopharmaceuticals; Sarcoidosis, Pulmonary; Survival Rate; Syndrome; Tomography, X-Ray Computed | 2013 |
Pediatric Burkitt's lymphoma and diffuse B-cell lymphoma: are surveillance scans required?
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Chemoradiotherapy; Child; Child, Preschool; Cohort Studies; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, B-Cell; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiation Dosage; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed | 2014 |
[Ineffective mefloquine therapy in progressive multifocal leukoencephalopathy complicated with malignant lymphoma: finding and usefulness of susceptibility-weighted imaging].
Topics: Disease Susceptibility; Female; Fluorodeoxyglucose F18; Humans; Leukoencephalopathy, Progressive Multifocal; Lymphoma, B-Cell; Mefloquine; Middle Aged; Positron-Emission Tomography; Treatment Failure | 2013 |
The utility and limitations of (18)F-fluorodeoxyglucose positron emission tomography with computed tomography in patients with primary mediastinal B-cell lymphoma: single institution experience and literature review.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Patient Outcome Assessment; Positron-Emission Tomography; Prognosis; Radiotherapy; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2015 |
A "PET" topic in primary mediastinal large B-cell lymphoma: positive or negative, and how to handle it in the end.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Utility of FDG-PET in primary renal lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphoma, B-Cell; Positron-Emission Tomography; Renal Insufficiency | 2015 |
The role of FDG-PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prednisone; Prognosis; Radiotherapy; Retrospective Studies; Rituximab; Survival Analysis; Tumor Burden; Vincristine; Young Adult | 2015 |
B-lymphoblastic lymphoma: a heartening diagnosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Differential; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Atria; Heart Neoplasms; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging, Cine; Mediastinal Neoplasms; Middle Aged; Positron-Emission Tomography; Risk Assessment; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Fluorodeoxyglucose-based positron emission tomography imaging to monitor drug responses in hematological tumors.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Fluorodeoxyglucose F18; Humans; Hydroxamic Acids; Lymphoma, B-Cell; Mice; Mice, Inbred C57BL; Positron-Emission Tomography; Vorinostat; Xenograft Model Antitumor Assays | 2014 |
[Prognostic value of PET-CT in patients with diffuse large B-cell lymphoma].
Topics: Adult; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiography; Remission Induction; Retrospective Studies; Treatment Outcome | 2014 |
Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, B-Cell; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed; Young Adult | 2015 |
A patient with a 12-year history characterized by four non-AIDS-related malignancies, occurring before and after the disclosure of HIV infection.
Topics: Carcinoma, Papillary; Fluorine Radioisotopes; Fluorodeoxyglucose F18; HIV Infections; Humans; Iodine Radioisotopes; Lymphoma, B-Cell; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Radionuclide Imaging; Syphilis; Thyroid Neoplasms; Thyroidectomy; Viral Load | 2015 |
Primary Pulmonary Diffuse Large B-Cell Lymphoma on FDG PET/CT-MRI and DWI.
Topics: Adult; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Fluorodeoxyglucose F18; Humans; Lung; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Prognostic Role of Pre-Radiation Therapy (18)F-Fluorodeoxyglucose Positron Emission Tomography for Primary Mediastinal B-Cell Lymphomas Treated with R-CHOP or R-CHOP-Like Chemotherapy Plus Radiation.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Retrospective Studies; Rituximab; Vincristine | 2016 |
Biological correlation between glucose transporters, Ki-67 and 2-deoxy-2-[18F]-fluoro-D-glucose uptake in diffuse large B-cell lymphoma and natural killer/T-cell lymphoma.
Topics: Cell Line; Fluorodeoxyglucose F18; Glucose; Glucose Transport Proteins, Facilitative; Humans; Ki-67 Antigen; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Natural Killer T-Cells | 2016 |
Intense focal pituitary FDG uptake due to intravascular large B-cell lymphoma in pyrexia of unknown origin.
Topics: Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Middle Aged; Pituitary Gland; Radiopharmaceuticals | 2016 |
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Leucovorin; Liver; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Recurrence; Rituximab; Statistics, Nonparametric; Vincristine; Young Adult | 2017 |
FDG PET to Diagnose Neurolymphomatosis in a Case of Triple-Hit B-Cell Lymphoma.
Topics: Animals; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Marek Disease; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2017 |
Intravascular large B-cell lymphoma with FDG accumulation in the lung lacking CT/(67)gallium scintigraphy abnormality.
Topics: Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung; Lung Neoplasms; Lymphoma, B-Cell; Middle Aged; Neoplasm Invasiveness; Prognosis; Radionuclide Imaging; Splenomegaly; Tomography, X-Ray Computed | 2009 |
Clinical significance of 18F-FDG uptake by primary sites in patients with diffuse large B cell lymphoma in the head and neck: a pilot study.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Incidence; Korea; Lymphoma, B-Cell; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate | 2008 |
Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas.
Topics: Aged; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Hexokinase; Humans; Immunohistochemistry; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged | 2009 |
High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Flow Cytometry; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; ROC Curve; Tomography, X-Ray Computed; Young Adult | 2009 |
F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2009 |
[18F-FDG uptake of lymphoma lesions of various histological subtypes].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ki-67 Antigen; Lymphoma, B-Cell; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2009 |
Lymphomatous meningosis diagnosed with [18F]-fluorodeoxyglucose-positron-emission tomography/CT.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Meningeal Neoplasms; Positron-Emission Tomography; Radiculopathy; Tomography, X-Ray Computed | 2009 |
Acute renal failure due to primary bilateral renal large B-cell lymphoma: diagnostics and follow-up by FDG-PET/CT.
Topics: Acute Kidney Injury; Biopsy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kidney; Kidney Neoplasms; Lymphoma, B-Cell; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Assessment of metabolic response to radioimmunotherapy with 90Y-ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
Topics: Aged; Analysis of Variance; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Positron-Emission Tomography; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Radioimmunotherapy; Radiopharmaceuticals; ROC Curve; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2010 |
Lymphoma of the superior vena cava detected with FDG PET/CT.
Topics: Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Vascular Neoplasms; Vena Cava, Superior | 2009 |
Solitary intradural extramedullary lymphoma of the cervical spine.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Cervical Vertebrae; Chemotherapy, Adjuvant; Cytarabine; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Injections, Spinal; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Rituximab; Spinal Neoplasms; Treatment Outcome | 2010 |
Dose-response relationship in cyclophosphamide-treated B-cell lymphoma xenografts monitored with [18F]FDG PET.
Topics: Animals; Cell Line, Tumor; Cyclophosphamide; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Mice; Positron-Emission Tomography; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays | 2010 |
Primary mediastinal large B-cell lymphoma (thymic lymphoma) imaged with F-18 FDG PET-CT.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
18F-FDG PET/CT in a case of intravascular large B-cell lymphoma.
Topics: Blood Vessels; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Metabolic activity measured by F-18 FDG PET in natural killer-cell lymphoma compared to aggressive B- and T-cell lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Fluorodeoxyglucose F18; Humans; Killer Cells, Natural; Lymphoma, B-Cell; Lymphoma, T-Cell; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Young Adult | 2010 |
18F-FDG PET/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretation.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymphoma, B-Cell; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2011 |
F-18 FDG PET/CT detecting thyroid plasmacytoma after the successful treatment of gastric large B-cell lymphoma.
Topics: Aged, 80 and over; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Plasmacytoma; Positron-Emission Tomography; Stomach Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Value of FDG PET in the evaluation of therapy response in nerve root neurolymphomatosis.
Topics: Animals; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Middle Aged; Positron-Emission Tomography; Spinal Nerve Roots; Treatment Outcome | 2011 |
Use of prechemotherapy positron emission tomography-CT imaging, acquired in the treatment position, to help plan involved nodal radiotherapy for a patient with diffuse large B-cell lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2011 |
Case of the season: Large B-cell lymphoma involving both breasts.
Topics: Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Cytarabine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2011 |
Local recurrence as immunoglobulin G4 (IgG4)-related disease 10 years after radiotherapy to ocular adnexal extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
Topics: B-Lymphocytes; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Immunohistochemistry; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Orbital Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
F-18 FDG uptake in hemorrhoids in a patient with diffuse large B-cell lymphoma.
Topics: Aged; Fluorodeoxyglucose F18; Hemorrhoids; Humans; Lymphoma, B-Cell; Male; Radionuclide Imaging; Radiopharmaceuticals | 2012 |
FDG PET/CT of bilateral testicular lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Middle Aged; Positron-Emission Tomography; Testicular Neoplasms; Tomography, X-Ray Computed | 2012 |
Intravascular large B-cell lymphoma with diffuse FDG uptake in the lung by 18FDG-PET/CT without chest CT findings.
Topics: Aged; Biological Transport; Diffusion; Fluorodeoxyglucose F18; Humans; Lung; Lymphoma, B-Cell; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
FDG-PET/CT findings of peritoneal lymphomatosis.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, B-Cell; Male; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Neurolymphomatosis diagnosed by (18)F-FDG PET-CT.
Topics: Biopsy, Fine-Needle; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Middle Aged; Multimodal Imaging; Nervous System Neoplasms; Radionuclide Imaging | 2013 |
The role of FDG-PET scanning in assessing lymphoma in 2012.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; France; Hodgkin Disease; Humans; Immunotherapy; Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Rare lymphoid malignancies of the breast: report of two cases illustrating potential diagnostic techniques.
Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Mammography; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2012 |
Assessment of tumor burden and treatment response by 18F-fluorodeoxyglucose injection and positron emission tomography in patients with cutaneous T- and B-cell lymphomas.
Topics: Adult; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma, B-Cell; Lymphoma, T-Cell, Cutaneous; Male; Neoplasm Staging; Radiopharmaceuticals; Skin Diseases; Tomography, Emission-Computed; Treatment Outcome | 2002 |
18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2003 |
Erythema nodosum associated with diffuse, large B-cell non-Hodgkin lymphoma detected by FDG PET.
Topics: Diagnosis, Differential; Erythema Nodosum; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
Differential FDG accumulation associated with GLUT-1 expression in a patient with lymphoma.
Topics: Excitatory Amino Acid Transporter 2; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals | 2003 |
Acute renal failure as the first presenting sign of non-Hodgkin's lymphoma.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma, B-Cell; Male; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome | 2004 |
False-positive finding on 18F-FDG PET after chemotherapy for primary diffuse large B-cell lymphoma of the thyroid: a case report.
Topics: False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 2004 |
F-18 FDG positron emission tomography findings in primary pancreatic lymphoma.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Diffuse F-18 FDG uptake in skeletal muscles secondary to chills resulting from sepsis: a cause for underestimation of viable tumor.
Topics: Adult; Bone Marrow Neoplasms; Chills; Diffusion; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Muscle, Skeletal; Positron-Emission Tomography; Radiopharmaceuticals; Sepsis | 2004 |
[Usefulness of FDG-PET in monitoring effects of the modality therapy for central nervous system malignant lymphoma: report of three cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Treatment Outcome; Vincristine | 2004 |
F-18 FDG PET and Ga-67 scintigraphy in a case of fever of unknown origin with underlying cutaneous diffuse large B-Cell lymphoma.
Topics: Citrates; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Gallium; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Skin Neoplasms | 2004 |
Extensive skeletal muscle uptake of 18F-FDG: relation to immunosuppressants?
Topics: Adult; Diagnosis, Differential; Drug Interactions; Female; Fever; Fluorodeoxyglucose F18; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Lymphoma, B-Cell; Muscle, Skeletal; Mycophenolic Acid; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Tacrolimus; Tomography, X-Ray Computed | 2004 |
PET-CT imaging of combined brachial and lumbosacral neurolymphomatosis.
Topics: Adult; Brachial Plexus; Fluorodeoxyglucose F18; Humans; Lumbosacral Plexus; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2005 |
Multiple nodular adenosis concurrent with primary breast lymphoma: pitfall in PET.
Topics: Adult; Breast Neoplasms; Diagnosis, Differential; Female; Fibrocystic Breast Disease; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
B cell lymphoma: a case with localized involvement of the prostate on F-18-FDG examination.
Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Prostatic Neoplasms; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Subtraction Technique; Urinary Retention | 2005 |
F-18 FDG positron emission tomography in non-Hodgkin lymphoma of the breast.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Rare Diseases | 2005 |
High-grade lymphoma of the bladder visualized on PET.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Severity of Illness Index; Urinary Bladder Neoplasms | 2005 |
Images in cardiovascular medicine. Primary lymphoma of the heart.
Topics: Aged; Echocardiography; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Positron-Emission Tomography; Remission Induction | 2005 |
Usefulness of [18F]FDG-PET kinetic analysis in non-enhancing primary central nervous system lymphoma: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Kinetics; Lymphoma, B-Cell; Middle Aged; Models, Biological; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Treatment Outcome; Vincristine | 2005 |
18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2006 |
Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas.
Topics: Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2006 |
Delayed [(18)F]FDG PET imaging of central nervous system lymphoma: is PET better than MRI?
Topics: Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymphoma, B-Cell; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2006 |
Periaortic lymphoma as a mimic of posttraumatic intramural hematoma.
Topics: Accidents, Traffic; Aged, 80 and over; Aorta, Thoracic; Axilla; Contrast Media; Diagnosis, Differential; Fluorodeoxyglucose F18; Hematoma; Humans; Lymph Nodes; Lymphoma, B-Cell; Lymphoma, Follicular; Male; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
False-positive axillary lymph node on FDG-PET/CT scan resulting from immunization.
Topics: Axilla; Diagnosis, Differential; Diagnostic Errors; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Immunization; Lymph Nodes; Lymphatic Metastasis; Lymphoma, B-Cell; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Viral Vaccines | 2006 |
18F-Fluorodeoxyglucose positron emission tomography for evaluation of intravascular large B-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prednisolone; Tomography, Emission-Computed; Vascular Neoplasms; Vincristine | 2007 |
Hodgkin's and non-Hodgkin's lymphomas.
Topics: Age Factors; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Remission Induction; Rituximab; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
[F-18]-Fluoro-2-deoxy-D: -glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model.
Topics: Animals; Cancer Vaccines; Cell Line, Tumor; Early Diagnosis; Female; Fluorodeoxyglucose F18; Imaging, Three-Dimensional; Immunocompetence; Immunotherapy, Active; Injections, Intravenous; Liver; Lymph Nodes; Lymphoma, B-Cell; Mast-Cell Sarcoma; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Positron-Emission Tomography; Radiopharmaceuticals; Spleen; Tail | 2007 |
Thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma concurrently diagnosed with a diffuse large B-cell lymphoma localized in the neck.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Nodule; Whole Body Imaging | 2007 |
Meningeal recurrence of intravascular large B-cell lymphoma: early diagnosis with PET-CT.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Meningeal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Stem Cell Transplantation; Treatment Outcome | 2007 |
Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymphoma, B-Cell; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Early therapeutic response assessment by (18)FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Failure | 2007 |
F-18 FDG uptake due to acinetobacter infection causing misinterpretation of treatment response in a lymphoma patient.
Topics: Acinetobacter Infections; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lymphoma, B-Cell; Middle Aged; Prednisone; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vincristine | 2007 |
Respective prognostic values of germinal center phenotype and early (18)fluorodeoxyglucose-positron emission tomography scanning in previously untreated patients with diffuse large B-cell lymphoma.
Topics: Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Germinal Center; Humans; Immunophenotyping; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Proteins; Positron-Emission Tomography; Prognosis; Survival Rate | 2007 |
Pericardial involvement in a non-Hodgkin lymphoma patient: coregistered FDG-PET and CT imaging.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cardiomegaly; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphoma, B-Cell; Male; Pericardial Effusion; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed; Vincristine | 2007 |
Valproic acid monotherapy leads to CR in a patient with refractory diffuse large B cell lymphoma.
Topics: Antineoplastic Agents; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron-Emission Tomography; Recurrence; Remission Induction; Treatment Failure; Valproic Acid | 2007 |
Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography.
Topics: Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule | 2007 |
FDG-PET detection of primary bone marrow large B-cell lymphoma in a patient with hairy cell leukemia.
Topics: Adult; Bone Marrow Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Leukemia, Hairy Cell; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Aggressive and indolent non-Hodgkin's lymphoma: response assessment by integrated international workshop criteria.
Topics: Adolescent; Adult; Aged; Burkitt Lymphoma; Fluorodeoxyglucose F18; Humans; International Cooperation; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
A 18F-FDG-positive, 67Ga-negative, and transferrin receptor expression-negative patient with diffuse large B-cell lymphoma.
Topics: Aged; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, B-Cell; Male; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Transferrin | 2007 |
[A case of neurolymphomatosis diagnosed with FDG-PET].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Diagnosis, Differential; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Positron-Emission Tomography; Remission Induction; Vincristine | 2007 |
Case records of the Massachusetts General Hospital. Case 26-2007 - a 61-year-old man with recurrent fevers.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Duodenum; Fever; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Radiography; Recurrence; Renal Insufficiency; Salvage Therapy; Vascular Neoplasms; Vincristine | 2007 |
Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; France; Humans; Image Interpretation, Computer-Assisted; Lymphoma, B-Cell; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate | 2007 |
Neurolymphomatosis--diagnosis and assessment of treatment response by FDG PET-CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
[The value of positron emission tomography/computed tomography (PET/CT) in the staging of diffuse large B-cell lymphoma].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Sacral nerve root neurolymphomatosis diagnosed on FDG-PET/CT and magnetic resonance imaging.
Topics: Aged; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sacrum; Spinal Nerves; Tomography, X-Ray Computed | 2008 |
Fat necrosis mimicking B-cell lymphoma: a PET/CT and FDG study.
Topics: Diagnosis, Differential; Fat Necrosis; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
[Primary bilateral adrenal T-cell lymphoma. A case report rarer than B-cell lymphoma].
Topics: Adrenal Gland Neoplasms; Aged; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Incidence; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Multiple Organ Failure; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
The use of PET-18FDG imaging in the clinical evaluation of head and neck lymphoma.
Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hyperplasia; Lymph Nodes; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
F-18 FDG positron emission tomography demonstrates resolution of non-Hodgkin's lymphoma of the parotid gland in a patient with Sjogren's syndrome: before and after anti-CD20 antibody rituximab therapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Parotid Neoplasms; Radiopharmaceuticals; Rituximab; Sjogren's Syndrome; Tomography, Emission-Computed | 2002 |